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Ire1 is an ancient transmembrane sensor of ER stress
with dual protein kinase and ribonuclease activities.
In response to ER stress, Ire1 catalyzes the splicing
of targetmRNAs in a spliceosome-independentman-
ner. We have determined the crystal structure of the
dual catalytic region of Ire1at 2.4 A˚ resolution, reveal-
ing the fusion of a domain, which we term the KEN
domain, to the protein kinase domain. Dimerization
of the kinase domain composes a large catalytic sur-
face on the KEN domain which carries out ribonucle-
ase function. We further show that signal induced
trans-autophosphorylation of the kinase domain per-
mits unfettered binding of nucleotide, which in turn
promotes dimerization to compose the ribonuclease
active site. Comparison of Ire1 to a topologically dis-
parate ribonuclease reveals the convergent evolution
of their catalytic mechanism. These findings provide
a basis for understanding the mechanism of action
ofRNaseLandotherpseudokinases,which represent
10% of the human kinome.
INTRODUCTION
Endoplasmic reticulum (ER) stress is characterized by the accu-
mulation of toxic misfolded protein aggregates in the ER lumen
(Bernales et al., 2006; Ron and Walter, 2007). Ire1 is an evolution-
arily conserved, ER stress sensor present in all eukaryotes with
both protein kinase and ribonuclease activities (Sidrauski and
Walter, 1997). These activities are critical for the induction of
the Unfolded Protein Response (UPR), a complex set of homeo-
static mechanisms evolved to cope with ER stress in eukaryotes
by promoting protein folding and maturation in the ER (Bernales
et al., 2006; Ron and Walter, 2007).
Ire1 detects elevated unfolded protein levels in the ER and
transmits a signal to the nucleus by splicing mRNAs encoding
master transcriptional regulators of the UPR response—Hac1pin yeast and Xbp1 in metazoans—independent of the spliceo-
some (Calfon et al., 2002; Lee et al., 2002; Sidrauski and Walter,
1997; Yoshida et al., 2001). Ire1 cleaves a single phosphodiester
bond in each of two RNA hairpins (with nonspecific base-paired
stems and loops of consensus sequence CNCNNGN, where N is
any base)(Gonzalez et al., 1999) to remove an intervening intron
from target transcripts. A second enzyme, the yeast tRNA ligase
Rlg1, joins the adjacent exons to generate a mature transcript
(Gonzalez et al., 1999; Sidrauski et al., 1996) (the metazoan ho-
molog of Rlg1 has yet to be identified). Removal of the intron in-
troduces a frame shift that yields a functional activator of the
UPR (Calfon et al., 2002; Lee et al., 2002; Mori, 2003; Sidrauski
and Walter, 1997; Yoshida et al., 2001). The mature forms of
Xbp1 and Hac1 execute the UPR transcription program to upre-
gulate the expression of a multitude of gene products including
ER-resident proteins that promote protein folding and matura-
tion and ER-associated proteins involved in protein degradation
(Travers et al., 2000).
Ire1 is a type I transmembrane receptor consisting of an N-ter-
minal ER luminal domain, a transmembrane segment and a cyto-
plasmic region. The cytoplasmic region of Ire1 encompasses
a protein kinase domain followed by a C-terminal extension of
150 residues. The X-ray crystal structure of the luminal domain
of yeast and human Ire1 have been determined (Credle et al.,
2005; Zhou et al., 2006), shedding light into signal-dependent
dimerization/oligomerization of the receptor. No structural infor-
mation has been forthcoming for the cytoplasmic/enzymatic
portion of the protein. The cytoplasmic region of Ire1 contains
its catalytic activities and is related to the antiviral ribonuclease
RNaseL, which is thought to share a common ribonuclease
mechanism. Unlike Ire1, RNaseL lacks protein kinase activity
and cleaves single-stranded RNA to inhibit protein synthesis in
response to viral stress (Floyd-Smith et al., 1981). While kinase
activity seems expendable in the ribonuclease mechanism of
RNaseL, and by inference that of Ire1, the structural integrity of
the kinase domains of both Ire1 and RNaseL are, paradoxically,
essential for their ribonuclease functions. Incidentally, neither
Ire1 nor RNaseL display sequence similarity to known nucleases.
Structural and biophysical characterization of the luminal do-
main of human and yeast Ire1 supports the notion that Ire1 hasCell 132, 89–100, January 11, 2008 ª2008 Elsevier Inc. 89
Figure 1. Sequence Conservation in the Dual-Catalytic Core of Ire1
Structure-based sequence alignment of the protein kinase domain and KEN (Kinase Extension Nuclease) domain of Ire1 sequences from S. cerevisiae (yeast),
H. sapiens (human), M. musculus (mouse), R. norvegicus (rat), G. gallus (chicken), X. laevis (frog), D. melanogaster (fruitfly), A. mellifera (honey bee), C. elegans
(nematode), A. thaliana (mouse-ear cress), andO. sativa (rice); and RNase L sequences fromH. sapiens (human), P. pygmaeus (orangutan),M.musculus (mouse),90 Cell 132, 89–100, January 11, 2008 ª2008 Elsevier Inc.
a propensity to dimerize upon exposure to unfolded protein in
the ER lumen. In analogy to many transmembrane receptor ki-
nases, the signal induced dimerization/oligomerization of human
and yeast Ire1 in the plane of a membrane is thought to promote
trans-phosphorylation on positive regulatory sites within the pro-
tein kinase domain (minimally Ser 840 and Ser 841 in yeast Ire1)
by juxtaposing two kinase domains in close proximity and thus to
induce its cytoplasmic kinase activity (Shamu and Walter, 1996;
Welihinda and Kaufman, 1996).
In addition to effecting a change in its protein kinase catalytic
function, dimerization and autophosphorylation of Ire1 lead to
the activation of its ribonuclease activity (Sidrauski and Walter,
1997). Interestingly, the ribonuclease function of Ire1 is also
greatly potentiated in vitro by the binding of nucleotide (either
ADP or ATP and its nonhydrolysable analogs, with ADP having
the greatest effect) (Sidrauski and Walter, 1997) presumably to
the kinase domain active site. The mechanism by which receptor
dimerization, kinase domain autophosphorylation and nucleo-
tide binding regulate ribonuclease function remains an open
question. In addition, the absence of similarity between Ire1
and any previously characterized ribonuclease enzyme leaves
the basis by which Ire1 (and by extension RNaseL) binds and
cleaves RNA a complete mystery.
To gain mechanistic insight into the basis of RNA cleavage by
Ire1 and the regulatory link between its ribonuclease and protein
kinases catalytic functions, we have solved the 2.4 A˚ X-ray crystal
structure of a cytoplasmic region of Ire1 encompassing the pro-
tein kinase domain and C-terminal kinase extension. Together
with mutational and functional analyses on Ire1 performed in vitro
and in vivo, these studies further our understanding of how Ire1
transduces a signal across the ER membrane in response to
the detection of unfolded protein in the ER lumen.
RESULTS
A survey of N- and C-terminal boundaries uncovered a minimal
cytosolic fragment of yeast Ire1 (residues 658–1115), denoted
Ire1cyto, that expressed well in bacteria as a TEV protease cleav-
able polyhistidine tag fusion, and that displayed regulatory and
catalytic properties of the full-length protein (Cox et al., 1993;
Mori et al., 1993; Sidrauski and Walter, 1997). Ire1cyto is active
as a protein kinase as evidenced by its steady-state phosphory-
lation status following purification fromE. coli lysates (see change
in electrophoretic mobility following phosphatase treatment in
Figure S1A available online) and its ability to autophosphorylate
in an enzyme concentration-dependent manner in the presence
of g-[32P]-ATP (Figure S1B). Mass spectroscopy analysis re-
vealed stoichiometric phosphorylation on two previously charac-
terized regulatory sites (Ser840 and Ser841) (Shamu and Walter,
1996) and two sites with no known regulatory function (Thr844,
and Ser850) within its activation segment (Figure S1C). Mutation
of Thr844 but not Ser850 severely impaired Ire1 function in vivo,as observed for mutation of Ser841 and to a lesser degree Ser840
(Figure S1D). Ire1cyto cleaves model RNA substrates such as
a tandem hairpin substrate derived from human Xbp1, denoted
XBP1mini (Figures S3A and S3B) and a single hairpin substrate
modeled on the 30 splice junction hairpin of yeast Hac1 (Figures
S4A and S4B), at the physiologically relevant loop positions.
RNA cleavage of Xbp1mini was potentiated by dimerization (com-
pare Ire1cyto +/ fusion to a GST dimerization domain), the pres-
ence of nucleotide (compare Ire1cyto +/ ADP) with a preference
for ADP over the nonhydrolyzable ATP analog AMPPNP (com-
pare Ire1cyto +ADP versus Ire1cyto +AMPPNP), and the phosphor-
ylation status of the enzyme (compare Ire1cyto wild-type and a ki-
nase domain active site mutant) (Figures S3B–S3E, respectively).
Crystals derived from Ire1cyto were not suitable for structure
determination. To improve the crystallizability of Ire1cyto, we en-
gineered a variant, denoted Ire1cytoD24, containing a 24 residue
(C869–F892) internal deletion within the kinase domain that re-
moves a protease labile loop. This loop deletion did not affect
the enzymatic properties of the protein in vitro (Figure S3F).
Only in the presence of the nucleotide ADP did Ire1cytoD24 yield
crystals (space group P65, a = b = 130.3 A˚, c = 175.0 A˚,
a = b=90,g=120,with two Ire1cytoD24molecules in the asymmet-
ricunit) suitable for structuredetermination using theselenomethio-
nine single anomalous dispersion method (see Experimental
Procedures). A near complete model of Ire1cytoD24, lacking 14
N-terminal residues and three internal sequences corresponding
to flexible loops, was refined to Rfactor/Rfree values of 23.8%/
27.2% to 2.4 A˚ resolution. The model displayed good geom-
etry and Ramachandran statistics commensurate with the
resolution of this study. Data collection and refinement statis-
tics are summarized in Table S1. A representative region of
experimentally phased electron density is shown in
Figure S5A. A structure-based sequence alignment of the
protein kinase domain and conserved C-terminal extension
of Ire1, and for comparison RNaseL, is shown in Figure 1.
Ribbon representations of the Ire1 structure are shown in Fig-
ures 2 and S5B.
Structure of the Ire1 Protomer
Ire1cytoD24 forms a dimer in the crystal environment (Figure 2).
Each Ire1 protomer (i.e., half of the dimer) consists of an N-termi-
nal kinase-domain followed by a 132 residue globular domain
formed by the conserved C-terminal kinase extension. We
have termed the latter domain the kinase-extension nuclease
(KEN) domain for reasons explained later in this study.
The kinase domain possesses a prototypical bilobal fold with
a smaller N-terminal lobe (N-lobe) and a larger C-terminal lobe
(C-lobe). The N-lobe (residues 673 to 748) consists of a twisted
5-strand anti-parallel b sheet (denoted b1 to b5) and a laterally
flanking helix aC (Figure S5B). The C-lobe (residues 749–982) is
comprised of two paired antiparallel b strands (b7-b10 and b8-
b9) and 11 a helices (aD to aL). Positioned between b strand 10R. norvegicus (rat), and C. familiarus (dog). Residues invariant across the Ire1-RNaseL family of kinase-ribonucleases are highlighted in blue, while residues in-
variant or highly conserved specifically in Ire1 are colored in green and yellow, respectively. The secondary structure of S. cerevisiae Ire1 is indicated above the
alignment using the coloring scheme of Protomer 1 in Figure 2A. A conserved disordered region in the KEN domain termed ‘‘Putative RNA specificity determi-
nants’’ is delineated by a black-box. The kinase domain activation segment of Ire1 is indicated by a set of black arrows. Dashed lines represent unmodeled dis-
ordered regions of the crystal structure.Cell 132, 89–100, January 11, 2008 ª2008 Elsevier Inc. 91
and helix aEF (and corresponding to residues 828–859) is the
activation segment, which serves a phosphoregulatory function
in many protein kinases including Ire1 (Nolen et al., 2004). In the
Ire1cytoD24 crystal structure, a major portion of the activation seg-
ment (residues 836–852) is disordered. We interpret this to reflect
the dynamic nature of the activation segment in its phosphory-
lated productive state. Lastly, Ire1 possesses a noncanonical
helix, denoted aE’, inserted between b strands b8 and b9 of the
C-lobe. This helix resides on the back-side of the protein kinase
domain where it participates indimer formation (discussed below).
Visible within the interlobe cleft of each Ire1cytoD24 protomer is
a fully resolved ADP molecule (Figure S5A). The binding of ADP
gives rise to a closed conformation of the bi-lobal kinase domain
compatible with the phosphor-transfer mechanism. Indeed, all
invariant active site residues among protein kinases that play
a role in nucleotide binding or in the phosphotransfer mechanism
are positioned in a productive manner (Figure S5B) (reviewed in
(Huse and Kuriyan, 2002)).
Figure 2. Structure of Ire1
(A) Ribbons representation of the dimeric dual-
catalytic region of Ire1 encompassing the protein
kinase domain and KEN domain. The kinase
N-lobe, C-lobe and the KEN domain are colored
green, orange, and blue (protomer 1) and light
green, yellow, and light blue (protomer 2), respec-
tively. ADP and coordinating metal ions are shown
within the kinase domain catalytic cleft. Two inter-
nal regions within the kinase domain and one inter-
nal region within the KEN domain not modeled due
to disorder are shown as dashed lines.
(B) A continuous hydrophobic core connects the
kinase C-lobe and the KEN domain. Residues
originating from the C-lobe and KEN domain are
colored in pink and green, respectively. Ribbons
diagram color scheme corresponds to that of pro-
tomer 2 in (A).
(C) Detailed stereoview of the KEN domain dimer
as shown in (A). Disordered regions corresponding
to putative RNA specificity determinants are
shown as red dashed lines.
(D and E) Dimer interface interactions involving
conserved residues in the kinase domain (D) and
the KEN domain (E), respectively, viewed along
the two fold axis of rotational symmetry. For clar-
ity, only residues targeted for mutation in this
study are shown in ball and stick representation.
Residues colored yellow and white originate from
promoter 1 and 2, respectively. Ribbons coloring
scheme corresponds to that in (A).
Extending immediately from the C-lobe
of the kinase domain is the KEN domain.
The disposition of the KEN domain on the
opposite face of the kinase domain
C-lobe, relative to the N-lobe, gives rise to
an elongated trilobal structure (Figure 2A).
As assessed by Dali (Holm and Sander,
1995) and VAST (Madej et al., 1995),
the eight a helices (denoted a1–a8,
Figure 2C) of the KEN domain com-
prise a novel fold. Within this fold, only a six residue con-
served sequence (Asn1036–Arg1041) between helices a3
and a4 is disordered. The hydrophobic nature of the inter
domain contact surfaces appears to enforce a fixed orienta-
tion between the KEN domain and the C-lobe of the kinase
domain and a co-dependence for proper folding (Figure 2B).
This might explain our inability to express stable forms of the
individual KEN and kinase domains (data not shown). Se-
quence conservation across Ire1 and RNaseL orthologs sug-
gests that the KEN domain structure and its relative orienta-
tion to the adjacent kinase domain will be shared by RNaseL
(Figure 1).
Dimerization of Ire1
Ire1cytoD24 adopts a parallel back to back dimer configuration re-
lated by a noncrystallographic 2-fold rotation about the long axis
of the protomer. The larger of two discontinuous dimerization
surfaces is composed by the kinase domain (Figure 2A) and92 Cell 132, 89–100, January 11, 2008 ª2008 Elsevier Inc.
buries a total of 2400 A˚2 of area. Residues on this surface include
N672, F694, R697, T720, D723, R730, Y731, S783, H787, R810,
D814, and Q816 (Figure 1 and 2D). Residues projecting from the
N-lobe (specifically b strands b2, b3, b4, and helix aC) are well
conserved across Ire1 orthologs, while those from the
C-lobe, (projecting from the nonconical helix aE’ and its flanking
linker sequences) appear specific to yeast Ire1.
Comparison of the Ire1cytoD24 structure to previously deter-
mined protein kinase domain structures reveals great similarity
to the dimer configurations of the eIF2a protein kinase PKR
(RMSD = 3.72 A˚) (Figure S5C) and the Mycobacterium tubercu-
losis protein kinases PknB, and PknE (Gay et al., 2006; Ortiz-
Lombardia et al., 2003; Young et al., 2003). Since signal induced
dimerization of PKR (Dey et al., 2005) and the Pkn family kinases
(Greenstein et al., 2007) serves to allostrerically regulate their ki-
nase activities, this similarity raises the possibility of a similar role
for dimerization in regulating Ire1 protein kinase function.
The second noncontiguous dimerization surface of Ire1cytoD24,
is composed entirely by the KEN domain (Figure 2A). Residues on
Figure 3. Sequence Conservation of Ire1
Reveals the Ribonuclease Active Site
(A) Surface representations of the Ire1cyto dimer.
Frontal view (left panel) and bottom view (top right
panel) are colored as in Figure 2A with all highly
conserved/invariant residues highlighted in red.
Bottom right panel displays a bottom view of
Ire1cyto colored according to electrostatic poten-
tial. The axis of two-fold noncrystallographic sym-
metry is indicated in each view.
(B) Expanded bottom view of a highly conserved
surface on the KEN domain. Invariant or highly
conserved side chains are displayed in yellow
ball and stick representation. The red dashed lines
indicate the position of disordered linkers corre-
sponding to putative determinant of RNA specific-
ity. Residues within the disordered linker are
shown in inset.
this 1320 A˚2 surface, including E988,
K992, I999, Y1059, M1063, V1076,
Q1107, and I1108, (Figures 1 and 2E).
While the majority of these residues are
different in the metazoans orthologs, the
positions are nevertheless conserved
within the metazoan Ire1 group, suggest-
ing that the same dimer configuration of
the KEN domain might be accessed by
all Ire1 orthologs.
Localization of the Putative
Ribonuclease Active Site
on the KEN Domain
The dimer configuration of Ire1cytoD24
gives rise to an extensive concave sur-
face on the bottom of the KEN domain.
This surface represents the most con-
served region of the whole Ire1cytoD24
dimer structure (Figure 3A). Within the
ordered part of this surface reside three highly conserved resi-
dues (D995, E998, R1053) and four invariant residues (Y1043,
R1056, N1057 and H1061) (Figure 3B). Within the disordered
part of the surface, consisting of a six residue linker connecting
helices a3 and a4, reside five highly conserved residues (N1036,
L1037, R1039, Y1040, and R1041) (Figure 3B). Based on (1) the
pocket-like nature of this surface, (2) the observation that four or-
dered residues, namely Y1043, R1056, N1057, and H1061, are
invariant across the larger Ire1/RNaseL ribonuclease family
(which likely share a common ribonuclease catalytic mechanism)
(Figures 1 and 3B) and (3) the observation that R1056 and H1061
in Ire1 (R667 and H672 in human RNaseL) are essential for ribo-
nuclease function (Dong et al., 2001), we reason that this surface
comprises the ribonuclease active site of Ire1. We test this hy-
pothesis experimentally below.
Mutational Analysis of the Ire1 Dimer Contact Surfaces
Based on the similarity of the dimer configuration of Ire1cytoD24 to
the kinase domain structures of PKR and PknB/E, we reasonedCell 132, 89–100, January 11, 2008 ª2008 Elsevier Inc. 93
Figure 4. Kinase Domain and KEN Domain
Dimerization Surfaces Are Important for
Ire1 Ribonuclease Function
(A) Autoradiograms of radiolabelled Xbp1mini
cleavage products generated by wild-type and
the indicated single-site dimer interface mutants
of Ire1cyto (top) or single-site and double-site
charge reversal mutants of Ire1cyto (bottom). The
percentage substrate cleaved is indicated below
each lane. Note the marked improvement in cleav-
age efficiency observed when the charge reversal
mutations R697D and D723R or D723R and
R730D are combined. All cleavage reactions
were performed using identical enzyme and sub-
strate concentrations.
(B) Ire1 null yeast strains transformed with wild-
type or the indicated dimer interface mutants of
full-length FLAG tagged-Ire1 were grown to satu-
ration and 4 ml of 10-fold serial dilutions (starting
OD600 = 1.0) were spotted on minimal medium sup-
plemented with essential nutrients (SD) or medium
containing 0.25 mg/ml tunicamycin. (Bottom panel)
Western analysis of Ire1 expression in yeast. 30 mg
of yeast whole-cell extracts, prepared as de-
scribed previously (Kimata et al., 2004), were sep-
arated by SDS-PAGE and then immunoblotted us-
ing monoclonal anti-FLAG antibodies (Sigma) or
with anti-eIF2a antibodies as a control.that the observed mode of Ire1 dimerization might play an essen-
tial role in regulating protein kinase activity. Alternatively, based
on the possibility that the ribonuclease active site of Ire1 resides
within a composite surface spanning two KEN domains, we rea-
soned that the Ire1cytoD24 dimer configuration might play an es-
sential role in regulating ribonuclease function. To test these
models, we introduced site-specific mutations at dimer interface
positions of Ire1cyto and tested in vitro ribonuclease and protein
kinase functions of recombinant mutant proteins expressed in
bacteria.
Wild-type Ire1cyto cleaved Xbp1mini, yielding the expected
products (Figure 4A). In contrast, alanine substitution of kinase
domain dimer interface residues R697, D723, and R730 (Fig-
ure 2D) or charge reversal mutations R697D, D723R, R730D,
greatly perturbed ribonuclease function (Figure 4A). Similarly,
KEN domain dimer interface mutations including E988Q,
K992D, and Y1059A (Figure 2E), greatly compromised the ability
to cleave Xbp1mini. In contrast to the potent effect on ribonucle-
ase function, none of the aforementioned dimer interface muta-
tions perturbed protein kinase catalytic function (Figures S2A,
S2B, and S2E). Together these results indicate that, in stark con-
trast to PKR, residues comprising the kinase domain and KEN
domain dimer interfaces are essential for the ribonuclease but
not the protein kinase function of Ire1.
We next tested whether the double-charge reversal mutations
R697D/D723R and D723R/R730D, could restore ribonuclease
function by reconstituting a dimer spanning salt-bridge in Ire1cyto
(Figure 4A, bottom panel). As shown in Figure 4A, both R697D/
D723R and D723R/R730D double-mutant proteins displayed
partial (two-fold) improvement in ribonuclease function relative
to the most perturbing single-site mutant proteins (i.e., R697D
and R730D, respectively). These results strongly support the no-94 Cell 132, 89–100, January 11, 2008 ª2008 Elsevier Inc.tion that the specific dimer configuration of Ire1cytoD24 observed
in the crystal structure is critically important for the ribonuclease
function of Ire1.
Consistent with a requirement of the kinase domain dimer in-
terface residues R697, D723, and D730 for ribonuclease func-
tion, charge reversal mutations at these positions inactivated
yeast Ire1 in vivo without affecting protein levels (Figure 4B, com-
pare vector and WT lanes). In addition, these kinase domain
dimer interface mutations blocked the tunicamycin-induced
activation of a lacZ reporter gene under the control of a UPR
element from the yeast KAR2 gene (Figure S6). In contrast to
the partial restoration of ribonuclease activity observed in vitro,
combining the R697D and D723R or the D723R and R730D
mutations failed to rescue growth on medium containing tunica-
mycin or activation of the tunicamycin-inducible lacZ reporter
(Figures 4B and S6). These data indicate that the salt bridge in-
teractions spanning the kinase domain dimer interface are nec-
essary for Ire1 function in vivo. The inability of yeast expressing
the double-charge reversal Ire1 mutants to grow on medium
containing tunicamycin may indicate that the partial restoration
of ribonuclease activity provided by combining these mutations
is below the threshold level required for yeast cell growth.
Mutational Analysis of the Candidate
Ribonuclease Active Site
To assess the importance of residues within the candidate ribo-
nuclease active site of Ire1cyto, we introduced site specific muta-
tions into Ire1cyto and tested the mutant recombinant proteins for
function as for the dimer interface mutants described above. We
first investigated conserved residues on the ordered portion of
the KEN domain surface (Figure 3B). We found that the D995A,
Y1043A, R1053E, R1056A, N1057A, and H1061A mutant
Figure 5. Disruption of the Putative Ribonu-
clease Active Site Abrogates Ribonuclease
Function
(A) Autoradiograms of radiolabelled Xbp1mini
cleavage products generated by wild-type and
the indicated single-site mutants of Ire1cyto within
the ordered conserved surface of the KEN domain
(top) and the disordered conserved linker adjoin-
ing helix a3 and a4 (bottom).
(B) Ire1 null yeast strains transformed with wild-
type or the indicated KEN domain single-site mu-
tants of full-length FLAG tagged-Ire1 were spotted
on minimal medium supplemented with essential
nutrients (SD) or medium containing 0.25 mg/ml tu-
nicamycin. (Bottom panels) Western analyses of
Ire1 expression in yeast. 30 mg of yeast whole-
cell extracts, prepared as described previously
(Kimata et al., 2004), were separated by SDS-
PAGE and then immunoblotted using monoclonal
anti-FLAG antibodies (Sigma).proteins displayed a complete loss of RNA cleavage function
(Figure 5A, upper panel), without an apparent loss of protein
kinase function (Figures S2C and S2E). We next investigated
conserved residues within a disordered loop connecting KEN
domain helices a3 and a4 (Figure 3B). We found that the
L1037A, R1039A, Y1040A, and R1041A, but not N1036A mutant
proteins, were greatly deficient for ribonuclease function (Fig-
ures 5A and 5B) but not protein kinase function (Figure S2D).
As was observed with the kinase domain interface mutants, the
ribonuclease active site mutants blocked Ire1 function in yeast.
Mutation of both the ordered and the disordered ribonuclease ac-
tive site residues abrogated Ire1 function in yeast (Figures 5B and
S7). Together, our in vitro and in vivo mutational results provide
compelling support to the notion that the concave surface on
the KEN domain embodies the ribonuclease active site of Ire1.
ADP Binding Promotes Ire1cyto Dimerization
Our structural and functional studies thus far indicate that as a ri-
bonuclease, Ire1 functions as a dimer. To investigate the oligo-
merization state of Ire1cyto in solution, we performed analytical
ultracentrifugation. In its apo form, Ire1cyto behaves as a homoge-
neous monomer in solution over all protein concentrations tested
(6.1–24.6 mM) (Figure S8). In contrast, the solution behavior of
Ire1cyto transitions to a monomer-dimer equilibrium in the pres-
ence of ADP with an approximate dissociation constant of
298 mM. Since nucleotide potentiates the ribonuclease activity
of Ire1, we reason that this phenomenon might reflect the ability
of ADP to promote the specific dimer configuration of Ire1cyto we
observe in the X-ray crystal structure.
Phosphorylation Status Regulates Access
of the Kinase Domain Active Site to Nucleotide
Given that nucleotide binding to the kinase domain appears to
stimulate Ire1cyto dimerization, we asked whether nucleotidebinding is a regulated process. Based on the ability of the activa-
tion segment to regulate access of nucleotide to the catalytic
cleft of other protein kinases (Hubbard et al., 1994; Huse and
Kuriyan, 2002), we performed isothermal titration calorimetry to
test if activation segment phosphorylation regulates nucleotide
access to the kinase domain. To do so, we compared binding
of ADP to Ire1cyto in its hyperphosphorylated active state versus
Ire1cyto in its nonphosphorylated state. We observed that hyper-
phosphorylated Ire1cyto displays a significant ADP binding signal
(Kd z20.4 mM; N z1) while nonphosphorylated Ire1
cyto and
a buffer only control displayed no sign of saturable binding to
ADP (Figure 6). From this data, we conclude that autophosphor-
ylation, presumably on regulatory sites within the activation seg-
ment, serves to regulate access of the kinase domain active site
to nucleotide binding.
Ribonuclease Catalytic Mechanism of Ire1
Our studies thus far have identified 10 of 458 residues in the
minimal catalytic region of Ire1 that are surface exposed, highly
conserved, clustered in space, and required for the ribonucleo-
lytic activity. Based on the likelihood that Ire1 and RNaseL share
a common RNA cleavage mechanism, we reasoned that the res-
idues directly involved in catalysis must be common to both en-
zymes. Only four residues in the Ire1 nuclease active site fulfill
this requirement, namely Y1043, R1056, N1057, and H1061.
We next assessed whether this group of four residues in Ire1
bears geometric and chemical similarity to the catalytic residues
in any of the 12 nonredundant ribonuclease folds represented in
the protein data bank. Within this group of ribonucleases, the
tRNA splicing endonuclease (PDB ID = 2GJW) displays a similar
composition of catalytic residues, (Y246, S258, H257, K287) to
the residues we identified for Ire1, despite a complete lack of sim-
ilarity in their three-dimensional folds (Figure 7). Superposition of
the catalytic residues in the tRNA endonuclease and Ire1 crystalCell 132, 89–100, January 11, 2008 ª2008 Elsevier Inc. 95
Figure 6. Ire1 Autophosphorylation Enables Nucleotide Binding
Isothermal titration calorimetry profiles obtained by titration of ADP against hyperphosphorylated wild-type Ire1cyto (left), a nonphosphorylated catalytically
inactive Ire1cyto(D797A) mutant (middle), and protein buffer control (right). The dissociation constant (Kd) and stoichiometry (N) obtained by fitting to a one-site bind-
ing model for wild-type Ire1 are shown in inset.structures reveals striking correspondence in both the chemical
nature and spatial disposition of functional groups (Figure 7A,
bottom panel), which allows us to infer the specific role of each
of the four residues in the Ire1 catalytic cluster.
As shown in Figure 7A (bottom panel), the imidazolium ring of
Ire1 H1061 aligns well with that of tRNA endonuclease H257,
which serves as a general acid to protonate the 50-OH leaving
group (Xue et al., 2006). The sidechain amide nitrogen of
N1057 in Ire1 aligns well with the backbone amide nitrogen of
tRNA endonuclease S258, which positions the scissile phos-
phate for nucleophilic attack. The guanidinium group of Ire1
R1056 and the amino group of the tRNA endonuclease K287,
which stabilizes the negatively charged transition state, are sim-
ilarly disposed. Only the hydroxyl group of Y1043 is shifted 5 A˚
from its expected postion relative to Y246 in tRNA endonucle-
ase. Given that Y1043 resides within a flexible region of Ire1,
we reason that Y1043 reorients to the position occupied by
tRNA endonuclease Y246 to enable catalysis. Such a reposition-
ing might occur as a result of Ire1 binding to RNA substrates.
Consistent with the notion that Ire1 employs the same catalytic
mechanism as tRNA endonuclease and other 20-30 cyclizing ribo-
nucleases, wherein the 20-OH group adjacent to the scissile
phosphate plays a critical role in catalysis, substitution of the
conserved guanosine 50 to the scissile phosphate with deoxy-
guanosine completely abolishes cleavage of single hairpin sub-
strates by Ire1 (Figure S4B). Furthermore, Ire1 has also been
reported to generate products bearing 20-30 cyclic phosphate
termini (Gonzalez et al., 1999).96 Cell 132, 89–100, January 11, 2008 ª2008 Elsevier Inc.DISCUSSION
Model of Ire1 Regulation
Our results provide a basis for understanding how the protein ki-
nase and ribonuclease activities of Ire1 are regulated and how the
two distinct structural domains responsible for each activity are
functionally interconnected (Figure 7B). In its resting state, Ire1
resides in a monomeric form, in part because the cytoplasmic
and the ER luminal regions of the transmembrane receptor lack
a strong ability to dimerize or are prevented from dimerizing in
the absence of unfolded protein. In response to the accumulation
of unfolded protein in the ER, the luminal domain of Ire1 tightly
dimerizes (possibly oligomerizes) promoting the juxtaposition of
two cytoplasmic kinase domains in a face to face manner that
facilitates trans-autophosphorylation on regulatory sites within
the activation segment. This posttranslational modification pro-
vides unfettered access of the kinase domain to the binding of
nucleotide which in turn enables a back-to-back dimer configura-
tion involving discontinuous surfaces on the protein kinase and
KEN domains. This mode of dimerization generates a large two
fold symmetric catalytic surface on the base of the KEN domain
that is fully competent for ribonuclease function.
Regulation of Ribonuclease Function
by Nucleotide Binding
Protein kinase domains possess a bilobal architecture character-
ized by great interlobe flexibility (Huse and Kuriyan, 2002) that fa-
cilitates the exchange of ADP and phosphoprotein products with
ATP and protein reactants. As evidenced by crystallographic
studies, the binding of nucleotide (ATP/ADP) to the catalytic cleft
of protein kinase domains favors the adoption of a well defined
closed conformation compatible with the phosphor-transfer
mechanism (Huse and Kuriyan, 2002). In the Ire1cyto crystal struc-
ture, this same closed nucleotide bound conformation of the
kinase domain appears conducive to dimer formation. Indeed,
we show that ADP binding actually promotes the ability of Ire1cyto
to form dimers in solution. Based on these observations, we rea-
son that nucleotide binding stabilizes dimer formation by limiting
the kinase domain from sampling alternate interlobe conforma-
tions that are incompatible with dimer formation. Since the
degree of lobe closure is very similar for kinase domains when
bound to ATP or ADP, this could explain why both molecules
(and also nonhydrolysable analogs of ATP) can potentiate ribonu-
clease function (Sidrauski and Walter, 1997). We were able to
reproduce the observation that ADP is a more potent stimulator
than ATP (Sidrauski and Walter, 1997). If this reflects tighter bind-
ing of ADP versus ATP, we speculate that the presence of the
Figure 7. Convergent Evolution of Ribonu-
clease Active Site
(A) Structural alignment illustrating concordance in
the three-dimensional disposition of ribonuclease
catalytic residues in Ire1 and tRNA endonuclease.
Sidechains of catalytic residues in the KEN do-
main of Ire1 are colored blue and the conserved
disordered linker connecting helices a3 and a4 is
demarked as a red dashed line (top). Catalytic res-
idues in the ribonuclease active site of a topologi-
cally disparate splicing ribonuclease – tRNA endo-
nuclease (PDB ID = 2GJW) are shown in pink,
while the bound RNA substrate analog is colored
in yellow (middle). For clarity, only the scissile
phosphate and the flanking nucleotides are
shown. RNA-protein interactions are indicated
with black dashed lines. Functionally analogous
residues in Ire1 (N1057,R1056, and H1061) and
tRNA endonuclease (S258, K287, and H257) align
very well, with the exception of Y1043 in Ire1,
which is displaced from the functionally equivalent
Y246 in tRNA endonuclease by 5 A˚ (bottom).
(B) Model of dimerization induced signaling by Ire1
across the ER membrane.
gamma phosphate moiety to ATP creates
greater electrostatic repulsion between
the quadruplely phosphorylated A-loop
than generated by ADP, and as a conse-
quence lowers the binding affinity of
ATP. This is manifested in the differential
effect of ADP versus ATP on Ire1 ribonu-
clease function (Figure S3D and [Si-
drauski and Walter, 1997]).
Regulation of Ribonuclease Activity
by the Activation Segment
The phosphorylation status of Ire1 affects
its ability to bind nucleotide and nucleo-
tide binding in turn promotes the ability
of Ire1 to dimerize. By analogy to the insu-
lin receptor kinase (Hubbard et al., 1994), we reason that the
activation segment in its dephosphorylated state engages the
active site of the kinase domain to inhibit nucleotide binding.
This might occur in a manner that locks the two kinase lobes in
a fixed orientation that is incompatible with dimerization or in
a manner that accentuates interlobe flexibility. The latter might
provide an entropic impediment to dimerization.
Interestingly, Papa et al. (2003) demonstrated that the binding
of the protein kinase inhibitor 1NM-PP1 to analog sensitive forms
of Ire1 had the effect of activating rather than inhibiting the down-
stream UPR signaling response. From this result, we reason that
the 1NM-PP1 inhibitor must bind to the kinase domain of Ire1 in
a manner that enforces a closed conformation of the kinase
domain similar to the ATP/ADP bound state and thus promotes
dimerization to activate ribonuclease function. If true, this raises
the possibility that other kinase domain targeting inhibitors of
Ire1 that enforce dimer-incompatible closure of the kinase
domain might serve to inhibit Ire1 ribonuclease function.Cell 132, 89–100, January 11, 2008 ª2008 Elsevier Inc. 97
Presumably, the binding mode of 1NM-PP1 to Ire1 is sufficiently
different from ADP that it is insensitive to the phosphorylation
status of the activation segment and hence bypasses the need
for autophosphorylation. Alternatively 1NM-PP1 might bind to
Ire1 with sufficient affinity that it competitively displaces any
inhibitory conformation of the activation segment.
Regulation of Ribonuclease Function by Dimerization
The requirement of dimerization for Ire1 ribonuclease function
suggests that certain functional determinants are supplied in
trans from opposing protomers. Consistent with the notion that
the core catalytic tetrad defining each ribonuclease active site
is constituted in cis (Figure 7A), mixing of active site mutants
did not restore nuclease activity (Figure S9). We surmise that
the functional component supplied in trans is represented by
the substrate recognition infrastructure, which may be provided
wholly or in part by opposing protomers in trans. Alternatively, if
all functional determinants are self-contained within each proto-
mer of Ire1, we surmise that dimerization serves to regulate each
catalytic center through an allosteric mechanism.
Implications of Twinned Catalytic Centers
in the Ire1 Nuclease Active Site
The Ire1 crystal structure reveals two catalytic centers symmet-
rically arrayed on adjacent KEN domains. Since the RNA hairpins
recognized by Ire1 are paired in its physiological substrates
(Mori, 2003), we reason that Ire1 may engage two hairpins coop-
eratively, perhaps as a mean to increase the affinity and specific-
ity of the interaction. Indeed, this might explain why tandem hair-
pin substrates are more efficiently cleaved than single hairpin
substrates (Gonzalez et al., 1999).
Since the two ribonuclease catalytic centers in the Ire1 dimer
are related by two-fold rotation symmetry, we reason that coop-
erative substrate recognition may be achieved when the two
hairpins in transcripts recognized by Ire1 are pre-ordered in
a two-fold symmetric structure. Consistent with this possibility,
the loop sequences of target hairpins are pseudo-palindromic
and display striking potential to base pair when aligned in a stag-
gered anti-parallel manner (Figure S10A). This pattern is reminis-
cent of kissing hairpin structures, which contain dyad symmetry
(Figure S10B). An interesting feature of the kissing hairpin model
is that it places the projected cleavage sites within adjacent hair-
pins in the same approximate distance of separation as the two
catalytic centers of the KEN domain dimer (11.5 A˚ in RNA model
versus 13.5 A˚ in KEN domain dimer). Close correspondence in
the distance of separation between twinned RNA cleavage sites
and twinned catalytic centers appears to be a requisite for sub-
strate recognition by tRNA endonuclease (Figure S10B and Xue
et al., 2006). Further understanding of Ire1’s ribonuclease cata-
lytic mechanism and the structural features of its RNA substrates
that mediate recognition awaits the structure of Ire1 in complex
with RNA.
Relevance to RNaseL
Ire1 and RNaseL compose a unique subfamily of proteins pos-
sessing a recognizable protein kinase domain and ribonuclease
activity. The latter is attributable to the presence of the KEN do-
main in both proteins. The ribonuclease activity of both enzymes
are regulated by dimerization, and potentiated by nucleotide98 Cell 132, 89–100, January 11, 2008 ª2008 Elsevier Inc.binding (Credle et al., 2005; Dong et al., 1994; Sidrauski and Wal-
ter, 1997; Zhou et al., 2006). We anticipate that RNaseL will also
adopt the same back-to-back dimer conformation in its active
state. Similarly, we anticipate that nucleotide binding to the
kinase domain of RNaseL promotes dimerization and hence
ribonuclease activity through a common mechanism.
Unlike Ire1, RNaseL lacks protein kinase catalytic function and
does not require autophosphorylation for the activation of its
ribonuclease function (Dong et al., 1994). Based on sequence
alignments (Figure 1), this might be explained by the complete
absence of an activation segment in RNaseL. In contrast to
Ire1, the absence of an activation segment would provide consti-
tutive access of the kinase domain active site to nucleotide bind-
ing. Thus, the primary mode of regulation for RNaseL would lie at
the level of dimerization which is promoted by the binding of virus
induced second messengers, namely 20-50 oligo-adenylate poly-
mers, to the N-terminal ankyrin repeat domain of RNaseL (Dong
and Silverman, 1995).
RNaseL targets a distinct class of RNA substrates from those
targeted by Ire1, cleaving singled stranded regions in both cod-
ing and noncoding RNAs (Floyd-Smith et al., 1981). We surmise
that differences in substrate preferences between Ire1 and
RNaseL are attributable in part to a disordered region connecting
helicesa3 anda4 in the KEN domain, whose sequence is unqiuely
conserved in each group of enzymes (Figure 1). Consistent with
this possibility, we showed that the residues in the disordered
region of Ire1 are essential for its ribonuclease function.
Comparison to PKR and Relevance for Pseudokinases
Despite close phylogenetic descent and similarity in the back-to-
back dimer configuration adopted by Ire1 and PKR, the effect of
dimerization on protein function is radically divergent. In the case
of PKR, kinase domain dimerization allosterically upregulates
phosphotransfer activity; in the case of Ire1, dimerization of the
kinase domain simply serves as a scaffold to bring two adjacent
KEN domains into a precise register that has no bearing on ki-
nase activity. In the extreme case of the pseudo-kinase RNaseL,
the kinase domain of RNaseL has completely lost phosphotrans-
fer function. In this regard, the structure of Ire1cyto provides a
basis for understanding the mechanism of action of other
pseudo-kinases which represent 10% of the 518 protein kinases
encoded in the human genome (Boudeau et al., 2006).
Recent studies have demonstrated frequent mutation of Ire1 in
human cancer genomes (Greenman et al., 2007) as well as the
direct involvement of the downstream target of Ire1, namely
Xbp1, in the development of multiple myeloma (Carrasco et al.,
2007). The work presented here provides a framework for dis-
secting the potentially complex relationship between Ire1 func-
tion and its role in disease such as cancer. Furthermore, this
work sheds light on potential therapeutic avenues for the positive
and negative manipulation of Ire1 signaling function.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Ire1cyto, and derivatives thereof, were recombinantly expressed from pProEx
(Invitrogen) or pGEX-2T (Pharmacia) plasmids in E. coli BL21 cells as TEV pro-
tease-cleavable His- or GST-tagged fusions, respectively. Expressed proteins
were bound to either Ni-NTA or glutathione Sepharose beads and eluted with
imidazole, or by TEV protease treatment, respectively, and further purified
by anion exchange (Q-Sepharose) and size exclusion (Superdex 200) chroma-
tography.
Crystallization, Data Collection, Structure
Determination, and Modeling
Ire1cytoD24 was produced as a His-tag fusion and labeled with seleno-methio-
nine in BL21 CodonPlus(DE3)-RIL cells (Stratagene). Crystals were obtained in
hanging drops containing purified Ire1cytoD24, and ADP mixed with an equal
volume of well solution containing 50 mM Tris-Cl (pH 8.0), 200 mM KOAc,
50 mM SrOAc, 10 mM MgCl2 and 10% PEG 8K. Crystals were cryoprotected
with lower well solution supplemented with 30% ethylene glycol prior to flash
freezing in liquid N2. A single anomalous dispersion experiment was performed
on beamline 19-BM (Advanced Photon Source, Argonne, IL). SHELX D
(Schneider and Sheldrick, 2002) was used to locate all 12 selenium sites.
Phase extensions were performed with SHELX E (Debreczeni et al., 2003).
Density modification and automated model building was performed using
RESOLVE (Terwilliger, 2003). The final model was generated using a combina-
tion of manual adjustment (COOT [Emsley and Cowtan, 2004]) and model
refinement (REFMAC5 [Vagin et al., 2004]) to a final resolution of 2.4 A˚ with
Rwork = 23.8% and Rfree = 27.2%.
In Vitro lPPase and RNA Cleavage Assays
The phosphorylation status of purified Ire1 proteins was assessed by incuba-
tion of ten-fold molar excess of Ire1 with lPPase in the presence of 0.1 mM
MnCl2 at 37
C followed by SDS-PAGE. For radiometric RNA cleavage assays,
Xbp1mini (50 GCGAAUUGGGUACCGUGGCGGCGCCUCCUGAGUCCGCAGC
ACUCAGACUC-UCUGCACCUCUGCAGCAGGUGCAGGCGCC 30) was tran-
scribed in vitro from a T7 promoter and labeled with a-[32P]-CTP. For fluores-
cent RNA cleavage assays, single RNA hairpins containing a 50-end fluores-
cein label were purchased from Dharmacon. Cleavage reactions were
performed as described in (Gonzalez et al., 1999).
Analytical Ultracentrifugation
Equilibrium sedimentation and data analysis was performed as described in
(Dey et al., 2005) using purified Ire1cyto prepared in 50 mM Tris-Cl (pH 7.0),
20 mM MgCl2, 20 mM KCl, and 0.5 mM TCEP in the absence or presence of
1 mM ADP.
Isothermal Titration Calorimetry
ITC was performed using a VP-ITC calorimeter (MicroCal). 2.5 mM ADP, 100 mM
Ire1cyto, and 100 mM Ire1cyto(D797A) were individually prepared in 50 mM Tris-Cl
(pH 7.0), 150 mM NaCl, 20 mM MgCl2, and 2 mM DTT. The ADP solution was
serially titrated into 1.35 mL of Ire1 protein solution or buffer control using 28
consecutive 10 ml injections at 240 s intervals at 20C. Resultant binding iso-
therms were processed using MicroCal Origin 5.0 software. The final model
was fitted to a one-site binding model.
Yeast Experiments
The entire yeast IRE1 gene including 1 kb of 50 and 0.3 kb of 30 flanking
sequence was amplified by PCR and cloned between the XhoI and EagI sites
of the low copy-number LEU2 vector pRS315 generating pC3059. Plasmid
pC3060 was derived from pC3059 by inserting a PstI site and FLAG epitope
(DYKDDDDK) immediately before the IRE1 stop codon. Plasmids
pC3061-pC3067 containing the IRE1 dimer-interface mutations R697A,
R697D, D732R, D730A, D730R, R697D-D730R, and D723R-R730D, respec-
tively, were generated in pC3060 by fusion PCR. Untagged versions of the
IRE1 mutants were generated by transferring an NheI-SacI fragment carrying
the mutations to pC3059. The nuclease active-site mutations were transferred
from the E. coli expression vectors to pC3060 generating the low copy-number
LEU2 plasmids pC2994-pC2997 and pC3032-pC3036 carrying the mutations
Y1043A, R1056A, N1057A, H1061A, R1053E, D995A, L1037A, Y1040A, and
R1041A, respectively. Mutant plasmids were introduced into yeast strain
F862 (MATa his3-D1 leu2-D0 met5-D0 ura3-D0 ire1::kanMX), obtained from
the yeast genome deletion collection, and tested for growth on SD minimal
medium supplemented with essential nutrients and 0.25 mg/ml tunicamycin.Supplemental Data
Supplemental Data include one table and ten figures and can be found with
this article online at http://www.cell.com/cgi/content/full/132/1/89/DC1/.
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